Conversations in Drug Development

Apr 25 2024
Conversations in Drug Development Podcast artwork

Welcome to Conversations in Drug Development, brought to you by the team at Boyds for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development. This podcast series features candid conversations from the expert team at Boyds, who are at the forefront of cutting-edge science and drug development in the pharmaceutical and biotechnology sector.

RSS feed Share
Copy RSS


Subscribe on Podcast Addict


How are GMO regulations impacting clinical development in Europe?

Apr 25 2024 24 mins  
In this episode of Conversations in Drug Development, our host Harriet Edwards, is joined by Director of Regulatory Affairs, Dr Sabine Ruehle, to discuss the challenges of navigating genetically modified organism (GMO) regulations in clinical trials within Europe. This discussion helps decipher the nuanced environment of GMOs and their associated risks unique within the European fr

US drug development: The latest regulatory trends and initiatives

Mar 19 2024 22 mins  
In this episode of Conversations in Drug Development, host Harriet Edwards is joined by Katie Rudnick and Dr Julie Warner from Boyds to discuss US regulatory trends and initiatives at the FDA.

The regulatory challenges of rare disease drug development

Feb 28 2024 29 mins  
To celebrate Rare Disease Day, we are back with another Conversation in Drug Development, this time discussing the unique challenges of rare disease drug development. Dr Eric Hardter, Associate Director of Regulatory Affairs at Boyds, joins our host Harriet Edwards to explore the need for early stakeholder involvement, the complexities of pediatric clinical trials, including ethica

The drug development landscape: Trends and predictions for 2024

Jan 22 2024 25 mins  
We are kickstarting 2024 with a Conversation in Drug Development with CEO and Founder of Boyds, Professor Alan Boyd. In this podcast episode, our host Harriet Edwards, and Professor Alan Boyd discuss trends from 2023 in the drug development space and its potential evolution in 2024. Join us as we explore the financial downturn affecting early-stage investment, the rise of cell and

Off-the-shelf cell therapies: Breaking barriers and revolutionizing patient care

Dec 04 2023 20 mins  
In this episode of "Conversations in Drug Development", Harriet Edwards and Dr. Patrick Ginty discuss off-the-shelf cell therapies, explaining how these therapies are manufactured and their ability to treat multiple recipients. While these therapies offer scalability and the potential to treat larger patient populations, they also carry risks such as immune reactions. Dr. Ginty hig

The future of drug development: AI’s role in revolutionizing the industry

Nov 08 2023 22 mins  
In this episode of Conversations in Drug Development, Dr. Julie Warner and Harriet Edwards discuss the revolutionizing role of artificial intelligence (AI) in drug development, exploring its applications in data analysis and toxicity prediction, and its potential to reduce animal testing.

Recent trends in oncology drug development

Oct 04 2023 24 mins  
In this episode of Conversations in Drug Development, Dr. Katherine Bowen delves deep into the ever-evolving world of oncology drug development and the regulatory landscape in the US and EU.